Profil
Dr. David Rikard M.
Holmdahl, MD PhD, is a Professor at Karolinska Institutet, Chairman at Redoxis AB, and a Professor at University of Turku.
He is on the Board of Directors at ProNoxis AB.
Dr. Holmdahl was previously employed as a Professor by University of Lund.
Postes actifs de David Rikard Martinsson Holmdahl
| Sociétés | Poste | Début |
|---|---|---|
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Develops preclinical drug and validates autoimmune diseases, with expertise in In Vivo models | Fondateur | 01/01/2007 |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 22/12/2009 |
University of Turku
University of Turku Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 26/07/2011 |
Anciens postes connus de David Rikard Martinsson Holmdahl
| Sociétés | Poste | Fin |
|---|---|---|
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2007 |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Turku
University of Turku Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Develops preclinical drug and validates autoimmune diseases, with expertise in In Vivo models | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Health Technology |
















